• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [304 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2008 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Intravenous topotecan (Hycamtin®)
2008 Agency for Healthcare Research and Quality (AHRQ) Positron emission tomography for nine cancers (bladder, brain, cervical, kidney, ovarian, pancreatic, prostate, small cell lung, testicular)
2007 Agency for Healthcare Research and Quality (AHRQ) Management of uterine fibroids: an update of the evidence
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer]
2007 New Zealand Health Technology Assessment (NZHTA) Performance of commercially available HPV tests
2007 Adelaide Health Technology Assessment (AHTA) Tam Pap for self testing of HPV
2007 Belgian Health Care Knowledge Centre (KCE) HPV vaccination for the prevention of cervical cancer in Belgium
2007 Canadian Agency for Drugs and Technologies in Health (CADTH) Human papillomavirus (HPV) vaccines: A Canadian update
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Review on the medical and health economic evidence for an inclusion of colposcopy in primary screening programs for cervical cancer]
2007 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical cancer]
2007 HAYES, Inc. ExAblate 2000 system (InSightec Ltd.) for ablation of uterine fibroids
2006 HAYES, Inc. Human papillomavirus vaccines for prevention of cervical cancer
2006 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Impedance-controlled endometrial ablation (Novasure(R)) - systematic review, expert panel
2006 NIHR Horizon Scanning Centre (NIHR HSC) Topotecan (hycamtin) for carcinoma of the cervix: horizon scanning technology ultra-orphan note
2006 National Institute for Health and Care Excellence (NICE) High dose rate brachytherapy for carcinoma of the cervix. NICE interventional procedures guidance 160
2006 New Zealand Health Technology Assessment (NZHTA) Review of the National Cervical Screening programme. Chapter 5: interim operational policy and quality standards 2000. Technical brief.
2006 National Institute for Health and Care Excellence (NICE) Endometrial cryotherapy for menorrhagia. NICE interventional procedures guidance 157
2006 HAYES, Inc. Human papillomavirus vaccines for prevention of cervical cancer
2006 Adelaide Health Technology Assessment (AHTA) Uterine artery embolisation for the treatment of symptomatic uterine fibroids
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Uterine artery embolization for the management of uterine fibroids
2006 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Operation for vaginal prolapse in day surgery - a health technology assessment]
2006 HAYES, Inc. Levonorgestrel-releasing intrauterine device for dysfunctional uterine bleeding
2006 HAYES, Inc. Luma cervical imaging system (MediSpectra Inc.) for detection of cervical intraepithelial neoplasia
2006 Belgian Health Care Knowledge Centre (KCE) Cervical cancer screening and Human Papillomavirus (HPV) testing
2005 Institute for Clinical Systems Improvement (ICSI) HPV DNA testing for the screening and monitoring of cervical cancer
2005 NIHR Health Technology Assessment programme Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK
2005 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [The use of liquid based cytology (LBC) and conventional pap smear (CPS) for cervical screening in Denmark]
2005 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Embolization in the treatment of uterine myoma]
2005 Medical Services Advisory Committee (MSAC) Endometrial ablation techniques for chronic refractory menorrhagia
2004 Quality Improvement Scotland (NHS QIS ) Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding
2004 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Endometrial ablation for menorrhagia
2004 Malaysian Health Technology Assessment Unit (MHTAU) Second generation endometrial ablation
2004 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of human papilloma virus (HPV) testing in primary screening for cervical cancer in France
2004 HAYES, Inc. Radiofrequency endometrial ablation for menorrhagia secondary to dysfunctional uterine bleeding
2004 NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling
2004 National Institute for Health and Care Excellence (NICE) Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding. NICE technology appraisal guidance 78
2004 ECRI Pap smear plus speculoscopy for cervical cancer screening
2004 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) PAP-test for the screening of cervical carcinoma: impact of different examination intervals
2004 HAYES, Inc. Computer-assisted screening methods for detecting cervical cancer
2004 Agency for Healthcare Research and Quality (AHRQ) Positron emission testing for six cancers (brain, cervical, small cell lung, ovarian, pancreatic and testicular)
2004 NIHR Health Technology Assessment programme Diagnosis of endometrial abnormality: comparison of outpatient procedures within cohorts defined by age and menopausal status
2004 National Institute for Health and Care Excellence (NICE) Photodynamic endometrial ablation. NICE interventional procedures guidance 47
2004 HAYES, Inc. Hybrid capture HPV testing for cervical cancer
2004 Medical Advisory Secretariat (MAS) Thermal balloon endometrial ablation for dysfunctional uterine bleeding (TBEA): an evidence-based analysis
2004 NIHR Health Technology Assessment programme Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status
2004 NIHR Health Technology Assessment programme Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis
2003 NIHR Health Technology Assessment programme The impact of screening on future health-promoting behaviours and health beliefs: a systematic review
2003 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Liquid-based cytology and human papillomavirus testing in cervical cancer screening
2003 NIHR Health Technology Assessment programme A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of womens preferences in the management of menorrhagia
2003 ECRI Automated thin-layer slide preparation systems for cervical cancer screening
2003 Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003 Institute for Clinical Systems Improvement (ICSI) Liquid-based cervical cytology
2003 HAYES, Inc. Thermal balloon and hydrothermal endometrial ablation
2003 HAYES, Inc. Thin-layer pap preparations for detecting cervical cancer
2003 HAYES, Inc. Uterine artery embolization for treatment of fibroids
2003 National Institute for Health and Care Excellence (NICE) Guidance on the use of liquid-based cytology for cervical screening. NICE technology appraisal guidance 69
2003 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Liquid-based slide preparations and automated devices in examining cercix smears - systematic review of medical efficacy and health economics, and decision analysis
2003 HAYES, Inc. Endometrial cryoablation
2003 HAYES, Inc. Endometrial laser ablation
2003 L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Assessment of metroplasty for uterine enlargement to treat uterine abnormalities following exposure to diethylstilbestrol: progress report
2003 Medical Services Advisory Committee (MSAC) Computer-assisted image analysis for cervical screening
2003 National Institute for Health and Care Excellence (NICE) Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids. NICE interventional procedures guidance 30
2003 National Institute for Health and Care Excellence (NICE) Laparoscopic laser myomectomy. NICE interventional procedures guidance 23
2003 Hannover Medical School, Medizinische Hochschule Hannover (MHH) Liquid-based slide preparations and automated devices in examining cervical smears - systematic review of medical efficacy and health economics, and decision analysis
2003 Medical Services Advisory Committee (MSAC) Cervical cancer screening (#12c)
2003 Quality Improvement Scotland (NHS QIS ) The use of liquid-based cytology for cervical screening (review)
2002 NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices in screening for cervical cancer - horizon scanning review
2002 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Uterine artery embolization for the treatment of fibroids
2002 Health Technology Advisory Committee (HTAC) Screening for cervical cancer: recent advances
2002 West Midlands Health Technology Assessment Collaboration (WMHTAC) Outpatient diagnosis of endometrial cancer in women with first episode of postmenopausal bleeding
2002 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Endometrial ablation techniques in the treatment of dysfunctional uterine bleeding
2002 Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2002 Agency for Healthcare Research and Quality (AHRQ) Screening for cervical cancer
2002 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Embolization of uterine fibroids - Early Warning on New Health Technology]
2002 Medical Services Advisory Committee (MSAC) Liquid based cytology for cervical screening
2002 HAYES, Inc. Levonorgestrel-releasing intrauterine device for dysfunctional uterine bleeding
2001 Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Early diagnosis of cervical cancer: current knowledge on old and new technologies
2001 Medical Services Advisory Committee (MSAC) Positron emission tomography [Part 2(i)]
2001 Medical Services Advisory Committee (MSAC) Magnetic resonance imaging for staging cervical and endometrial cancer
2001 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Use of mammography and Papanicolaou's test for the early detection of breast and uterine cervix cancer in Spain. IPE-02/34 (Public report)
2001 ECRI Uterine fibroid embolization for the treatment of fibroids
2001 Basque Office for Health Technology Assessment (OSTEBA) [Analysis and review of protocols and quality standards in the diagnostic process for the detection of cervical cancer]
2001 The Swedish Council on Health Technology Assessment (SBU) Human papillomavirus testing in primary cervical cancer screening - early assessment briefs (ALERT)
2001 Institute for Clinical Systems Improvement (ICSI) HPV DNA testing for cervical cancer
2001 ECRI Human papillomavirus DNA testing for diagnosis of cervical dysplasia and carcinoma
2001 HAYES, Inc. Laparoscopic sacrocolpopexy for vaginal vault repair
2000 NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices for the detection of cervical cancer - horizon scanning review
2000 NIHR Health Technology Assessment programme Liquid-based cytology in cervical screening: a rapid and systematic review
2000 Health Technology Advisory Committee (HTAC) Surgical alternatives to hysterectomy for abnormal uterine bleeding
2000 New Zealand Health Technology Assessment (NZHTA) Effectiveness and cost effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature
2000 ECRI Thermal uterine balloon endometrial ablation therapy for treatment of benign menorrhagia
2000 Centre for Clinical Effectiveness (CCE) The diagnostic characteristics of transvaginal ultrasound in the detection of endometrial cancer in postmenopausal women taking hormone replacement therapy
2000 Centre for Clinical Effectiveness (CCE) The bleeding patterns which can occur with long term hormone replacement therapy (HRT) and how they correlate with endometrial pathology
1999 West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness of the mirena coil (levonorgestrel-releasing intrauterine system) in menorrhagia
1999 University of York Management of gynaecological cancers
1999 Medical Services Advisory Committee (MSAC) Saline infusion sonohysterography
1999 Agency for Healthcare Research and Quality (AHRQ) Evaluation of cervical cytology
1999 Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Evaluation of the PAPNET-system in cervix screening - primary research
1998 Australian Health Technology Advisory Committee (AHTAC) Review of automated and semi-automated cervical screening devices
1998 Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Computer assisted analysis system for cervico-vaginal smears (systematic review, primary research, expert panel)